Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$93.49
-4.94%
Mkt Cap $5.86B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (20 analysts)
$115.00
Range $55.00 – $145.00
Implied Upside
+23.0%
Consensus $115.00 vs current $93.49
NASDAQ·Healthcare·Biotechnology
$93.49
-4.94%
Mkt Cap $5.86B
Buy
5
Hold
0
Sell
0
Price Target (20 analysts)
$115.00
Range $55.00 – $145.00
+23.0%
Consensus $115.00 vs current $93.49